Manufacturer record
Kerala State Drugs Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Kerala State Drugs Pharmaceuticals Ltd (Kerala) was declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DG 5033, Diclofenac Sodium Tablets IP 50 mg (exp Feb 2027). DTL, Thrissur (state lab) found it not of standard quality: The sample does not conform to IP standards with respect to the test Dissolution and also shows Category B defect of tablets (Capping). Listed in the July 2026 alert.
Records by type
1 record linked to Kerala State Drugs Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Sodium Tablets IP 50 mg | Batch DG 5033Mfg Mar 2025 · Exp Feb 2027 | The sample does not conform to IP standards with respect to the test Dissolution and also shows Category B defect of tablets (Capping).Dissolution | DTL, ThrissurState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.